MGNX
Income statement / Annual
Last year (2023), MacroGenics, Inc.'s total revenue was $58.75 M,
a decrease of 61.33% from the previous year.
In 2023, MacroGenics, Inc.'s net income was -$9.06 M.
See MacroGenics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
Operating Revenue |
$58.75 M
|
$151.94 M
|
$75.64 M
|
$97.76 M
|
$62.02 M
|
$60.12 M
|
$155.52 M
|
$86.58 M
|
$100.85 M
|
$47.26 M
|
Cost of Revenue |
$17.87 M |
$7.38 M |
$2.65 M |
$193.20 M |
$195.31 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Gross Profit |
$40.88 M |
$144.56 M |
$72.99 M |
-$95.44 M |
-$133.29 M |
$60.12 M |
$155.52 M |
$86.58 M |
$100.85 M |
$47.26 M |
Gross Profit Ratio |
0.7 |
0.95 |
0.96 |
-0.98 |
-2.15 |
1 |
1 |
1 |
1 |
1 |
Research and Development
Expenses |
$156.94 M
|
$207.03 M
|
$214.58 M
|
$193.20 M
|
$195.31 M
|
$190.83 M
|
$147.23 M
|
$122.09 M
|
$98.27 M
|
$70.19 M
|
General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$42.74 M
|
$46.06 M
|
$40.50 M
|
$32.65 M
|
$29.83 M
|
$22.77 M
|
$15.93 M
|
Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General &
Administrative Expenses |
$52.19 M
|
$58.95 M
|
$63.01 M
|
$42.74 M
|
$46.06 M
|
$40.50 M
|
$32.65 M
|
$29.83 M
|
$22.77 M
|
$15.93 M
|
Other Expenses |
$7.60 M |
$1.66 M |
-$1.80 M |
-$7.12 M |
-$2.16 M |
-$247,000.00 |
$2.52 M |
$1.51 M |
$42,000.00 |
$2,000.00 |
Operating Expenses |
$209.13 M |
$265.98 M |
$275.79 M |
$228.82 M |
$239.21 M |
$231.33 M |
$177.66 M |
$146.62 M |
$121.04 M |
$85.58 M |
Cost And Expenses |
$226.99 M |
$273.36 M |
$278.44 M |
$228.82 M |
$239.21 M |
$231.33 M |
$177.66 M |
$146.62 M |
$121.04 M |
$85.58 M |
Interest Income |
$9.69 M |
$1.70 M |
$2.00 M |
$800,000.00 |
$3.40 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Interest Expense |
$1.43 M |
$263,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Depreciation &
Amortization |
$9.65 M
|
$11.87 M
|
$11.26 M
|
$11.96 M
|
$12.30 M
|
$9.20 M
|
$7.23 M
|
$7.61 M
|
$2.86 M
|
$1.82 M
|
EBITDA |
-$158.60 M
|
-$121.42 M
|
-$202.80 M
|
-$131.06 M
|
-$166.34 M
|
-$162.93 M
|
-$22.14 M
|
-$60.04 M
|
-$17.32 M
|
-$38.32 M
|
EBITDA Ratio |
-2.7 |
-0.8 |
-2.68 |
-1.34 |
-2.68 |
-2.71 |
-0.14 |
-0.69 |
-0.17 |
-0.81 |
Operating Income Ratio
|
-2.86
|
-0.8
|
-2.68
|
-1.34
|
-2.86
|
-2.85
|
-0.14
|
-0.69
|
-0.2
|
-0.81
|
Total Other
Income/Expenses Net |
$159.19 M
|
$1.66 M
|
$680,000.00
|
$1.32 M
|
$25.37 M
|
-$247,000.00
|
$2.52 M
|
$1.51 M
|
$42,000.00
|
$2,000.00
|
Income Before Tax |
-$9.06 M |
-$119.76 M |
-$202.12 M |
-$129.74 M |
-$151.81 M |
-$171.45 M |
-$19.63 M |
-$58.53 M |
-$20.14 M |
-$38.31 M |
Income Before Tax Ratio
|
-0.15
|
-0.79
|
-2.67
|
-1.33
|
-2.45
|
-2.85
|
-0.13
|
-0.68
|
-0.2
|
-0.81
|
Income Tax Expense |
$9.48 M |
$263,000.00 |
-$11.26 M |
-$11.96 M |
$10.67 M |
-$247,000.00 |
-$7.23 M |
-$7.61 M |
$0.00 |
-$1.82 M |
Net Income |
-$9.06 M |
-$120.02 M |
-$190.86 M |
-$117.78 M |
-$151.81 M |
-$171.45 M |
-$19.63 M |
-$58.53 M |
-$20.14 M |
-$38.31 M |
Net Income Ratio |
-0.15 |
-0.79 |
-2.52 |
-1.2 |
-2.45 |
-2.85 |
-0.13 |
-0.68 |
-0.2 |
-0.81 |
EPS |
-0.15 |
-1.95 |
-3.18 |
-2.25 |
-3.16 |
-4.19 |
-0.54 |
-1.69 |
-0.63 |
-1.4 |
EPS Diluted |
-0.15 |
-1.95 |
-3.18 |
-2.25 |
-3.16 |
-4.19 |
-0.54 |
-1.69 |
-0.63 |
-1.4 |
Weighted Average Shares
Out |
$61.93 M
|
$61.41 M
|
$59.94 M
|
$52.44 M
|
$48.08 M
|
$40.93 M
|
$36.10 M
|
$34.69 M
|
$31.80 M
|
$27.37 M
|
Weighted Average Shares
Out Diluted |
$61.93 M
|
$61.43 M
|
$59.94 M
|
$52.44 M
|
$48.08 M
|
$40.93 M
|
$36.10 M
|
$34.69 M
|
$31.80 M
|
$27.38 M
|
Link |
|
|
|
|
|
|
|
|
|
|